MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Phar
Wisconsin Pharmacal Company
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
1 recall found for Wisconsin Pharmacal Company — April 2026.
The recalls listed below are active notices associated with Wisconsin Pharmacal Company in the FDA, NHTSA, USDA, and CPSC databases. 1 of these recall is classified as urgent, meaning the issuing agency has determined a reasonable probability of serious harm. The current recall involves sterility concerns. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.
A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.
Browse all medication recalls →Wisconsin Pharmacal Company
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.